Transcutaneous Imiquimod Combined With Anti‐Programmed Cell Death‐1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma

Documenti analoghi

• Preoperative Pyuria as a Predictor of False‐Positive Rates in the Photodynamic Diagnosis of Nonmuscle‐Invasive Bladder Cancer Using Oral 5‐Aminolevulinic Acid
  di: Shinkuro Yamamoto, et al.
  Pubblicazione: (2025)
• Successful Management of Tumor Lysis Syndrome Following Enfortumab Vedotin Plus Pembrolizumab Therapy in Metastatic Urothelial Carcinoma: A Case Report
  di: Daigo Takemori, et al.
  Pubblicazione: (2025)
• 3-Majority and 2-Choices with Many Opinions
  di: Shimizu, Nobutaka, et al.
  Pubblicazione: (2025)
• Quasi‐majority functional voting on expander graphs
  di: Nobutaka Shimizu, et al.
  Pubblicazione: (2024)
• Comment on “Association Between Preoperative 5‐Aminolevulinic Acid Administration Timing and Perioperative Hypotension”
  di: Shinkuro Yamamoto, et al.
  Pubblicazione: (2026)